INTRODUCTION
Carpal tunnel syndrome (CTS) is the most common upper limb compressive neuropathy, affecting 2.7% of the general population [1]. The diagnosis of CTS is usually established by history and physical examination. Electrophysiological studies help in CTS diagnosis and severity grading [2,3]. Another useful diagnostic tool is ultrasonography, which is painless, rapid and with reduced cost. The common and reproducible finding in compressive neuropathies is nerve enlargement just proximal to the site of entrapment [4,5]. Moreover, it detects structural abnormalities at the wrist in patients having CTS [6,7,8].
According to a paper of the American Association of Neuromuscular and Electrodiagnostic Medicine in 2012, ultrasonography measurement of the median nerve cross-sectional area (CSA) used to determine the median nerve enlargement at the wrist is accurate for the diagnosis of CTS [9]. Cutoff values of 9 or 10 mm2 were suggested as single diagnostic criterion in most previous studies [4,10,11,12,13,14]. Interestingly, several studies reveal that there is a positive correlation between the median nerve CSA and electrophysiological severities of CTS [15,16]. However, no well-designed study has been conducted for diagnosis of electrophysiologically moderate and severe CTS, which are to be considered for surgical treatment [17]. Therefore, the primary objective of the present study was to establish a cutoff of the median nerve CSA at the wrist, to determine electrophysiologically moderate and severe CTS.
MATERIALS AND METHODS
The present research was a prospective study conducted between May 2014 and October 2015. Eligibility criteria included Thai adults (18 years old or over) presenting with sensory symptoms (numbness and/or tingling) in at least 2 digits among 1, 2, 3, and 4 for at least 1 month [2], and able to communicate in Thai. Patients with clinically or electrophysiologically suspected other neurologic diseases such as polyneuropathy, cervical radiculopathy, or proximal median neuropathies, were excluded in advance. In addition, symptomatic wrists were excluded if they had deformities, space occupying lesions, history of steroid injection or wrist surgery (Fig. 1). Participants were enrolled prospectively, and written consent to participate in the present study was obtained. The study protocol was approved by the Institutional Review Board before participant enrollment (IRBRTA 085/2557).
Nerve conduction studies
A single physiatrist administered standard nerve conduction study (NCS) to all participants. The routine NCS for diagnosing CTS comprised 14-cm antidromic sensory median and ulnar peak latencies, 8-cm median and ulnar compound muscle action potential, distal motor latencies, and nerve conduction velocity (Medelec Synergy T5EP model; Oxford Instruments, Oxfordshire, UK). The CTS was diagnosed by following the protocol when 14-cm antidromic sensory median peak latency was more than 3.6 ms, or a 14-cm antidromic sensory peak latency difference of the median-ulnar ring finger (ring-diff) was equal to or more than 0.5 ms [2,18]. The NCS results were classified into four groups: no, mild, moderate, and severe CTS, following the recommendation of Stevens [19]. To establish the cut-off for moderate and severe CTS, participants were further categorized into two groups: 0=no and mild CTS; 1=moderate and severe CTS.
Ultrasonography
On the same day of NCS, all participants received ultrasonography (US) examination by a physiatrist who had 2 years of experience in neuromuscular US, and was blinded from NCS results. The examinations were conducted with a 14–16 MHz linear array transducer (ProSound Alpha 7; Hitachi-Aloka Medical, Tokyo, Japan). Participants were examined in the sitting position, with palm upward and resting on a pillow across the lap [5]. The CSA (mm2) of the median nerve of the symptomatic wrist was imaged and measured at the distal wrist crease (proximal to the carpal tunnel inlet) [4] using direct trace with electronic calipers, and considering the hyperechoic sheath as the margin [10]. The area of each wrist was averaged from three separate examinations. To assess inter-rater reliability, some participants were randomly sampled to be re-examined by another physiatrist with the same protocols and on the same day as the first examination; this physiatrist was blinded from both NCS and US results of the previous examiner.
Statistical analysis
The inter-rater reliability of US was assessed by intraclass correlation coefficients(2, 1). Next, the overall diagnostic value of US was evaluated by the area under the receiver operator characteristics (ROC) curve. Spearman rank correlation coefficient was used to assess the relationship between CSA and electrophysiological results. The data was analyzed for calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) across a range of the CSA (10 and 15 mm2 in 1 mm2 increments).
RESULTS
A total of 108 eligible patients (202 wrists) participated in the present study, but 14 wrists were excluded due to steroid injection or wrist surgery. In addition, 2 patients (3 wrists) were excluded due to no US results (Fig. 1). Of the 106 patients, the majority of participants were female (82.1%) with a mean age of 53.1±12.8 years, ranging from 28 to 89 years. Of the 185 wrists examined, 26.0% (48 wrists), 17.8% (33 wrists), 37.8% (70 wrists), and 18.4% (34 wrists) were documented by NCS as no, mild, moderate, and severe CTS, respectively. Additionally, inter-rater reliability was explored from 28 patients (48 wrists). The result showed that intraclass correlation coefficients(2, 1) was 0.93 (95% confidence interval, 0.87–0.96).
A mean±standard deviation of CSA of the median nerve of no, mild, moderate, and severe CTS was 9.4±2.1, 12.0±2.7, 13.8±4.7, and 15.4±4.1, respectively. A moderate degree of positive correlation between CTS severities and CSA was shown (Spearman rank correlation coefficient= 0.56) (Fig. 2). The CSA of the median nerve at the wrist had fair diagnostic abilities for moderate and severe CTS—area under the ROC curve=0.77 (95% CI, 0.70–0.83) (Fig. 3). According to ROC curve, an 11.5 mm2 CSA could be the best trade-off between sensitivity (69.2%) and specificity (67.9%). However, its power to rule in or to rule out was insufficient, since PPV and NPV were merely 73.5% and 63.2%, respectively. A 14 mm2 CSA had sufficient power to rule in moderate and severe CTS, with a specificity of 91.4% and sensitivity of 42.3% (Table 1). In addition, it showed a post-test probability (PPV) of 86.3% for a pre-test probability of 56.2%.
DISCUSSION
The US to measure CSA of the median nerve at the wrist is a useful test to determine moderate and severe CTS. The results of the present study revealed a positive correlation between CSA and CTS severities (rs=0.56), which was similar to previous studies [15,16,20]. The study of Mhoon et al. [20] and Moran et al. [16] reported 0.52 and 0.61 of positive correlation, respectively. However, the primary objective of both these studies differed from the current study. The study of Mhoon et al. [20] was undertaken to establish a cut-off to use US as a screening test of CTS, and suggested CSA of 9 mm2 as the cut-off with a sensitivity of 99% and specificity of 22%. The study of Moran et al. [16] aimed to determine the cut-off for CTS diagnosis. The study suggested US as the first CTS diagnostic tool, and that CSA of 9.8 mm2 (sensitivity of 92% and specificity of 45%) and 12.3 mm2 (sensitivity of 62% and specificity of 95%) should be used as the cut-off to rule out and to rule in CTS, respectively.
Some patients with electrophysiologically moderate and severe CTS were considered to receive surgical management. A highly sensitive diagnostic test is required to determine the condition. Hence, a 14 mm2 CSA with a sensitivity of 42.3% and specificity of 91.4% was preferred, rather than a 13 mm2 CSA having sensitivity of 52.9% and specificity of 80.3%. Moreover, if the cut-off was increased from 14 mm2 to 15 mm2, there was minimal increase in the specificity and PPV (2.4% and 1.5%, respectively), but there was a significant drop in sensitivity (7.7%).
Several studies suggested that the comparison of median nerve CSA between the proximal and distal site, CSA ratio or difference, might increase the diagnostic properties of US [21,22]. Nevertheless, the measurement of CSA at the proximal site showed low reliability. The study of Junck et al. [23] revealed that the intra-rater reliability of measurement of the median nerve CSA at the pronator quadratus were 0.29 for sonographers and 0.49 for radiologists, whereas the intra-rater reliability of measurement of median nerve CSA at carpal tunnel inlet were 0.87 for sonographers and 0.86 for radiologists. Therefore, median nerve CSA at wrist alone was used in the present study.
The present study had several strengths. Firstly, this constituted a prospective study with consecutive enrollment; the US examiner was blinded, and all examined wrists were suspected of having CTS to avoid spectrum bias, which was found in case-control studies. Secondly, the inter-rater reliability was excellent, which influenced the quality of the US information. Finally, both NCS and US were performed on the same day to prevent data error from disease progression.
On the other hand, some limitations were also observed. Firstly, the number of male participants in the present study was small (17.9% of participants). There were evidences that the CSA of median nerve at the wrist was significantly different between male and female; however, this evidence was observed in healthy subjects, and not in CTS patients [24,25,26]. Next, the US examiner had only 2 years of experience in neuromuscular US, which possibly affected validity of the US results. Lastly, the participants of this study were Thai people, and hence the results could differ in a population of different ethnicity, such as a European population.
In conclusion, US might be used to determine the electrophysiological severities of CTS. Patients with ≥14 mm2 of median nerve CSA had a very high probability to be moderate and severe CTS. However, if median nerve, CSA is less than 14 mm2, patients still required NCS to determine CTS severities.
PDF Links
PubReader
ePub Link
XML Download
Full text via DOI
Full text via PMC
Download Citation
